Program Details: Admission Notification 2024-2025 Program Director: Dr. Pramod Chinder Director, Orthopedic Oncology Duration: 18 months Eligibility: MS/DNB in Orthopedics Stipend: Provided Last Date to apply: 07th August 2024
Program Details Last date for receipt of completed application in prescribed format 30.06.2024 For More details click the link below Prospectus-and-Application-Form-of-Orthpedic-Oncology-Surgery-Fellowship-Programme (more…)
Admission Notification 2023-2024 Fellowship in Orthopedic Oncology (Affiliated to Rajiv Gandhi University of Health Sciences, Karnataka) Course Details Program Director Dr. Pramod Chinder, Director, Orthopedic Oncology Duration – 18
Nanavati Max Super Specialty Hospital is seeking talented individuals for the post of Clinical Associate in Orthopaedic Onco Surgery. Qualification: MBBS, MS / DNB Orthoaedics Required Experience: 1
Program Details: Fellowship Starts from : 1st April 2023 Vacancy of Fellowship position in orthopaedic oncology at Nanavati Max Superspeciality Hospital Mumbai Requirement: Minimum 2 yrs post MS
Program Overview The Musculoskeletal Oncology Fellowship Program at Rutgers New Jersey Medical School is ACGME accredited. The educational experience allows the fellow to have broad exposure to musculoskeletal
Number of Positions: 1-2 Duration: 1 year (July 1 to June 30) Location: BC Cancer Agency (BCCA), BC Children’s Hospital (BCCH), UBC Hospital (UBCH), and Vancouver General Hospital (VGH) Salary & Benefits: $60,000 + Benefits (if
Fellowship Director: Dr. Robert Turcotte. Length: 1 year Number of positions 1 Type of Fellowship: Clinical After completion of a 12 month rotation in orthopaedic oncology the fellow
Description: Stryker values the important and traditional contribution fellowships make to surgeon training to ensure good surgical outcomes and the proper use of medical technology products. FELLOWSHIP DOCUMENTS
The Musculoskeletal Oncology Fellowship Program at Rutgers New Jersey Medical School is ACGME accredited. The educational experience allows the fellow to have broad exposure to musculoskeletal neoplasms and